Alkem Laboratories climbs as the company to make equity investment in Sunsure Solarpark
Alkem Laboratories is currently trading at Rs. 5509.30, up by 120.85 points or 2.24% from its previous closing of Rs. 5388.45 on the BSE.
The scrip opened at Rs. 5388.45 and has touched a high and low of Rs. 5538.00 and Rs. 5388.45 respectively. So far 3549 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 6440.00 on 17-Sep-2024 and a 52 week low of Rs. 4409.90 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 5538.00 and Rs. 5342.75 respectively. The current market cap of the company is Rs. 65871.95 crore.
The promoters holding in the company stood at 55.66%, while Institutions and Non-Institutions held 28.23% and 16.10% respectively.
Alkem Laboratories together with its subsidiary M/s. Enzene Biosciences (Enzene) has entered into a Share Subscription and Shareholders’ agreement on December 17, 2024 with M/s. Sunsure Solarpark Twenty Two (Sunsure Solarpark) and M/s. Sunsure Energy for equity investment in Sunsure Solarpark. The said investment will be completed by the end of April, 2025.
Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
